CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ESALY

Perampanel Oral Suspension

Phase 2
Eisai (ESALY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
ESALYPhase 2

Perampanel Oral Suspension Phase 2 Est. Readout

Perampanel Oral Suspension
Q2 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in Pediatric Epileptic Syndrome

View Full Landscape
Drug Information

Target Indication

Pediatric Epileptic Syndrome

Clinical Trial

NCT04015141

Last updated: 12/27/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.